News & Updates

Show Multimedia Only

AI-based ECG predicts biventricular dysfunction, dilation in CHD

28 Aug 2024

An ECG enhanced by artificial intelligence (AI) demonstrates its capability in detecting biventricular dysfunction and dilation in patients with congenital heart disease (CHD).

AI-based ECG predicts biventricular dysfunction, dilation in CHD

28 Aug 2024

Rivaroxaban eases ischaemic events, ups bleeding in frail patients after revascularization

28 Aug 2024 by

The risks of ischaemic complications and bleeding are higher among patients with peripheral artery disease (PAD) who meet the frailty criteria after lower extremity revascularization in the VOYAGER PAD study. Regardless of frailty status, use of rivaroxaban lowers the ischaemic risk and increases bleeding.

Rivaroxaban eases ischaemic events, ups bleeding in frail patients after revascularization

28 Aug 2024

Corticosteroid elimination with anti–IL-5 antibody in two patients with idiopathic HES

28 Aug 2024 by

A 45-year-old male presented with generalized urticaria in September 2020. He had no past history of allergies, but had transient autoimmune thyroiditis in 2018, which subsequently resolved.

Corticosteroid elimination with anti–IL-5 antibody in two patients with idiopathic HES

28 Aug 2024

GLP-1 RAs offer CV benefits in T2DM

28 Aug 2024 by

Cardiovascular (CV) benefits of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) support their use in type 2 diabetes mellitus (T2DM). At a Novo Nordisk–sponsored lecture during the 6^th Annual Meeting of Endocrinology, Diabetes and Metabolism Hong Kong (EDM HK), Dr Julie Lovshin of the Division of Endocrinology and Metabolism, University of Toronto, Canada, reviewed clinical trials and real-world evidence on CV benefits provided by GLP-1 RAs, such as semaglutide, which led to guideline recommendations on their use in T2DM. Safety concerns related to GLP-1 RAs were also addressed.

GLP-1 RAs offer CV benefits in T2DM

28 Aug 2024

[Infographics] Don’t stop at HF: Screen for ATTR-CM

28 Aug 2024

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure (HF), affecting 1 in 10 patients with preserved left ventricular ejection fraction. Read this infographic to learn how to screen for ATTR-CM in HF patients and understand the survival benefits of early tafamidis treatment.

[Infographics] Don’t stop at HF: Screen for ATTR-CM

28 Aug 2024

Transthyretin amyloid cardiomyopathy: Tips for early diagnosis and treatment updates

28 Aug 2024

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, fatal condition that predominantly affects older adults. The prognosis is poor, with a median overall survival (OS) of 3–5 years. The condition is often underrecognized or misdiagnosed due to low disease awareness and fragmented knowledge among healthcare professionals across specialties. This article provides practical advice for early diagnosis and treatment, with a focus on 5-year OS data from the ATTR-ACT trial of tafamidis and key recommendations from the 2023 American College of Cardiology (ACC) guidelines.

Transthyretin amyloid cardiomyopathy: Tips for early diagnosis and treatment updates

28 Aug 2024

Clinical role of oral bempedoic acid in LDL-C management

28 Aug 2024 by

LDL-cholesterol (LDL-C) reduction is the key to preventing and treating atherosclerotic cardiovascular disease (ASCVD). Recent guidelines advocate aggressive LDL-C lowering in individuals at high or very high cardiovascular (CV) risk. At the Advances in Medicine 2024 conference, Dr Chu-Pak Lau, Specialist in Cardiology, discussed the clinical role of non-statin lipid-lowering therapies (LLTs), including oral bempedoic acid as a single agent or in fixed-dose combination (FDC) with ezetimibe, in patients who have failed to achieve guideline-recommended LDL-C targets or have statin intolerance.

Clinical role of oral bempedoic acid in LDL-C management

28 Aug 2024

STEMI criteria show similar accuracy in right BBB, non-BBB patients

27 Aug 2024

The ECG criteria used for identifying patients with ST-elevation myocardial infarction (STEMI) demonstrates similar diagnostic accuracy in right bundle branch block (BBB) and non-BBB patients, according to a study.

STEMI criteria show similar accuracy in right BBB, non-BBB patients

27 Aug 2024

Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success

27 Aug 2024 by

A screen-and-prevent strategy for preterm preeclampsia (PE), which involves screening in the first trimester and low-dose aspirin prophylaxis for high-risk women in <16–36 weeks of gestation, will be launched in obstetric units of public hospitals across Hong Kong following promising results from a multicentre Asian trial led by the Chinese University of Hong Kong (CUHK) and a pilot programme at the Prince of Wales Hospital (PWH).

Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success

27 Aug 2024

AI-reconstructed ECG facilitates heart monitoring with fewer leads

25 Aug 2024 by

Researchers have developed an artificial intelligence (AI) algorithm that can reconstruct an ECG from the standard 12 leads to just three, enabling faster and more accessible heart assessments.

AI-reconstructed ECG facilitates heart monitoring with fewer leads

25 Aug 2024

News & Updates

Filter by Specialty:

Specialty:

AI-based ECG predicts biventricular dysfunction, dilation in CHD

AI-based ECG predicts biventricular dysfunction, dilation in CHD

Rivaroxaban eases ischaemic events, ups bleeding in frail patients after revascularization

Rivaroxaban eases ischaemic events, ups bleeding in frail patients after revascularization

Corticosteroid elimination with anti–IL-5 antibody in two patients with idiopathic HES

Corticosteroid elimination with anti–IL-5 antibody in two patients with idiopathic HES

GLP-1 RAs offer CV benefits in T2DM

GLP-1 RAs offer CV benefits in T2DM

[Infographics] Don’t stop at HF: Screen for ATTR-CM

[Infographics] Don’t stop at HF: Screen for ATTR-CM

Transthyretin amyloid cardiomyopathy: Tips for early diagnosis and treatment updates

Transthyretin amyloid cardiomyopathy: Tips for early diagnosis and treatment updates

Clinical role of oral bempedoic acid in LDL-C management

Clinical role of oral bempedoic acid in LDL-C management

STEMI criteria show similar accuracy in right BBB, non-BBB patients

STEMI criteria show similar accuracy in right BBB, non-BBB patients

Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success

Preterm preeclampsia screen-and-prevent strategy to launch across HK’s public hospitals after initial success

AI-reconstructed ECG facilitates heart monitoring with fewer leads

AI-reconstructed ECG facilitates heart monitoring with fewer leads